PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer
Clinical trial NCT04099888 · TERMINATED
Trial details
- NCT number
- NCT04099888
- Sponsor
- PCI Biotech AS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-23
- Primary completion
- 2022-04-28
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.